Biomarkers classification and therapeutic decision-making for malignant gliomas. - Wikidata - wikimedia - TriplyDB

Biomarkers classification and therapeutic decision-making for malignant gliomas.

Biomarkers classification and therapeutic decision-making for malignant gliomas.

http://www.wikidata.org/entity/Q39556985

about

Spinal cord tumours: advances in genetics and their implications for treatment Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods Molecular Markers in Low-Grade Glioma-Toward Tumor Reclassification Diagnostic discrepancies in malignant astrocytoma due to limited small pathological tumor sample can be overcome by IDH1 testing Glial progenitors as targets for transformation in glioma.High metallothionein predicts poor survival in glioblastoma multiforme.High expression of VEGF and PI3K in glioma stem cells provides new criteria for the grading of gliomas.GATA4 and DcR1 methylation in glioblastomas.Signal transduction molecule patterns indicating potential glioblastoma therapy approaches.Gene markers in brain tumors: what the epileptologist should know.Prognostic and predictive biomarkers in adult and pediatric gliomas: toward personalized treatment.Beyond the World Health Organization grading of infiltrating gliomas: advances in the molecular genetics of glioma classification.Multigene profiling to identify alternative treatment options for glioblastoma: a pilot study.

P2860

Q26851596-61C7CEC9-B1DE-4AA1-AFCB-BFF2F892A14A Q26853516-AD8080F3-0753-4BB9-8D09-D3BC6AE2A4D3 Q28383205-38496E53-2FD7-4F4B-8EE4-5FD6215D0589 Q30810936-475D1F65-EAA1-4232-A083-2D6F3ADB6307 Q34735661-319AA152-975D-48C3-BE19-AC3FCD86F5B9 Q35817939-A66A00FE-1148-41C9-B9F3-5C3A15FEC10B Q36524261-1FE3CDBA-77F6-4C2F-9EE8-14E83A6C2F93 Q36690240-78930091-5306-43C8-BD15-F118D12BA7BD Q37360227-2E036C54-2BCE-4604-A05B-120121A0C6F1 Q37405669-78BB94CF-C1F9-494D-8DFE-C46F332DAE61 Q38203283-1043128E-D8D5-4985-90CD-E619DEEE76D3 Q38504172-839F4756-B8DD-4FC9-B809-889A3F1610F6 Q39217123-114C6C7A-DF26-4443-90E3-0ACC3D386275

P2860

Biomarkers classification and therapeutic decision-making for malignant gliomas.

http://www.wikidata.org/entity/Q39556985

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Biomarkers classification and therapeutic decision-making for malignant gliomas.

@en

Biomarkers classification and therapeutic decision-making for malignant gliomas.

@nl

type

label

Biomarkers classification and therapeutic decision-making for malignant gliomas.

@en

Biomarkers classification and therapeutic decision-making for malignant gliomas.

@nl

prefLabel

Biomarkers classification and therapeutic decision-making for malignant gliomas.

@en

Biomarkers classification and therapeutic decision-making for malignant gliomas.

@nl

P1433

Q39556985-DD726998-C54E-47B9-A768-268CC9143A24

P1476

Q39556985-BC11282A-9DCA-4257-BA45-C43DE929B2E7

P2093

Q39556985-7A1A14E3-BF56-4212-9FCA-FE42B28D8BBA

Q39556985-FCAB3513-4ACC-4121-AE94-426BCADF7F35

P2860

Q39556985-02E7589A-0C45-44DB-8715-0272BAF3557C

Q39556985-0820D65D-F91A-4AFB-9EA7-BD64B4E8CBF0

Q39556985-09FFB6F2-0B62-43A2-8A60-64E320D5C786

Q39556985-0C4A088F-1607-47C5-98A4-879B4E75C39D

Q39556985-0F352A3E-AFB6-46E7-BEC8-F5E56EC3BFFC

Q39556985-1457BE16-99A7-44A1-B9AF-80AC23C68D2B

Q39556985-146CAEFE-90DA-4BE8-A86F-C6549C5D3EC8

Q39556985-1E7B6695-3560-452F-83CB-9FA250A31E5E

Q39556985-2173B7FD-6F9F-45CE-A291-E4BE1409CE45

Q39556985-236BF404-C77F-4A02-B7D4-6AF315AF7535

P2888

Q39556985-07FC936F-1747-4C7F-A1F3-BD3E5D88ADE7

P304

Q39556985-48CDBCA3-E6CC-4CBA-9D40-690C0064964C

P31

Q39556985-E481FEDC-40C7-479C-9DF6-6DEEE2057ECD

P356

Q39556985-B2238227-9D65-4F69-A24E-42D773776E4C

P433

Q39556985-E5703DBB-06E2-4E9C-804A-906A36B7DC64

P478

Q39556985-5150F537-0440-466C-A9D0-CA11E2D5CBBC

P577

Q39556985-723C5313-996C-47E8-A2AA-52E373B8A9B8

P698

Q39556985-546D6BED-DB9C-4107-8028-842B8E3E5065

P921

Q39556985-14BA9936-3EBC-4F8F-9603-187C99B3A8BF

P356

S11864-012-0210-8

P1433

Current Treatment Options in Oncology

P1476

Biomarkers classification and therapeutic decision-making for malignant gliomas.

@en

P2093

Adriana Olar

http://www.w3.org/2001/XMLSchema#string

Kenneth D Aldape

http://www.w3.org/2001/XMLSchema#string

P2860

Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma

Recent advances in the molecular understanding of glioblastoma

The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13)

An integrated genomic analysis of human glioblastoma multiforme

IDH1 and IDH2 mutations in gliomas

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas

MGMT gene silencing and benefit from temozolomide in glioblastoma.

P2888

s11864-012-0210-8

P304

417-436

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11864-012-0210-8

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22956341

http://www.w3.org/2001/XMLSchema#string

P921